Efficacy and safety of fibrinogen concentrate in trauma patients-a systematic review

Journal of Critical Care

Volumn 29, Issue 3, 2014, Pages 471.e11-471.e17

  Aubron, C ^a   Reade, M C ^b   Fraser, J F ^b   Cooper, D J ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Blood transfusion; Coagulopathy; Fibrinogen concentrate; Injuries; Outcome

Indexed keywords

APROTININ; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; PLACEBO; PROTHROMBIN; PROTHROMBIN COMPLEX; TRANEXAMIC ACID; HEMOSTATIC AGENT;

BLEEDING; CAUSE OF DEATH; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; HYPOFIBRINOGENEMIA; INJURY; INTENSIVE CARE; INTERMETHOD COMPARISON; MORTALITY; MULTIPLE ORGAN FAILURE; PROPHYLAXIS; RESUSCITATION; REVIEW; SURVIVAL; SYSTEMATIC REVIEW; THROMBOCYTE TRANSFUSION; COMPLICATION; HEMORRHAGE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SAFETY;

FIBRINOGEN; HEMORRHAGE; HEMOSTATICS; HUMANS; OBSERVATIONAL STUDY AS TOPIC; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SAFETY; WOUNDS AND INJURIES;

EID: 84899959003     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.12.011     Document Type: Review

References (53)

1. Kauvar D.S., Lefering R., Wade C.E. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006, 60(6 Suppl):S3-S11.
2. Floccard B., et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 2012, 43(1):26-32.
3. Maegele M., et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007, 38(3):298-304.
4. Brohi K., et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?. Ann Surg 2007, 245(5):812-818.
5. Brohi K., Cohen M.J., Davenport R.A. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 2007, 13(6):680-685.
6. Frith D., et al. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost 2010, 8(9):1919-1925.
7. Hess J.R., et al. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008, 65(4):748-754.
8. Johansson P.I., et al. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Crit Care 2011, 15(6):R272.
9. Fenger-Eriksen C., et al. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008, 101(6):769-773.
10. Martini W.Z., Holcomb J.B. Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Ann Surg 2007, 246(5):831-835.
11. Schlimp C.J., et al. The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro. Blood Transf 2012, 1-9.
12. Martini W.Z. The effects of hypothermia on fibrinogen metabolism and coagulation function in swine. Metabolism 2007, 56(2):214-221.
13. Australian Society of Blood Transfusion. Clinical practice guidelines for the use of blood components: red blood cells, fresh frozen plasma, cryoprecipitate: the Australian Society of Blood Transfusion http://www.nhmrc.gov.au/_files_nhmrc/file/publications/synopses/cp78.pdf.
14. Spahn D.R., et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013, 17(2):R76.
15. Franchini M., Lippi G. Fibrinogen replacement therapy: a critical review of the literature. Blood Transf 2012, 10(1):23-27.
16. CSL Behring, B.f.L., RiaSTAP product information http://www.cslbehring.com.au/docs/992/827/Riastap_AU-PI_NZ-DS_3.00,0.pdf.
17. Malone D.L., et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 2003, 54(5):898-907.
18. Vlaar A.P., Schultz M.J., Juffermans N.P. Transfusion-related acute lung injury: a change of perspective. Neth J Med 2009, 67(10):320-326.
19. Gorlinger K., et al. Management of hemorrhage in cardiothoracic surgery. J Cardiothorac Vasc Anesth 2013, 27(4 Suppl):S20-S34.
20. Gorlinger K., et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011, 115(6):1179-1191.
21. Weber C.F., et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012, 117(3):531-547.
22. Kozek-Langenecker S., et al. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care 2011, 15(5):R239.
23. Meyer M.A., et al. Fibrinogen concentrates for bleeding trauma patients: what is the evidence?. Vox Sang 2011, 101(3):185-190.
24. Liberati A., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009, 6(7):e1000100.
25. Brenni M., et al. Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. Acta Anaesthesiol Scand 2010, 54(1):111-117.
26. Schochl H., et al. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia 2010, 65(2):199-203.
27. Schochl H., et al. High-dose fibrinogen concentrate for haemostatic therapy of a major trauma patient with recent clopidogrel and aspirin intake. Scand J Clin Lab Invest 2010, 70(6):453-457.
28. Grassetto A., et al. Rotational thromboelastometry analysis and management of life-threatening haemorrhage in isolated craniofacial injury. Blood Coagul Fibrinolysis 2012, 23(6):551-555.
29. Danes A.F., et al. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang 2008, 94(3):221-226.
30. Schochl H., et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011, 15(2):R83.
31. Wafaisade A., et al. Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge. J Trauma Acute Care Surg 2013, 74(2):387-393. discussion 393-5.
32. Weiss G., et al. Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register. Blood Coagul Fibrinolysis 2011, 22(8):727-734.
33. Nienaber U., et al. The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury 2011, 42(7):697-701.
34. Innerhofer P., et al. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013, 44(2):209-216.
35. Schochl H., et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010, 14(2):R55.
36. Doyle S., et al. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coagul Fibrinolysis 2003, 14(3):283-287.
37. Rahe-Meyer N., et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 2013, 118(1):40-50.
38. Rahe-Meyer N., et al. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. J Thorac Cardiovasc Surg 2013, 145(3 Suppl):S178-S185.
39. Fenger-Eriksen C., et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009, 7(5):795-802.
40. Karlsson M., et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009, 102(1):137-144.
41. Dickneite G., et al. Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P). Blood Coagul Fibrinolysis 2009, 20(7):535-540.
42. Warmuth M., Mad P., Wild C. Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta Anaesthesiol Scand 2012, 56(5):539-548.
43. Fries D. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. Transfusion 2013, 53(Suppl 1):91S-95S.
44. Fries D., et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth 2005, 95(2):172-177.
45. Stinger H.K., et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008, 64(2 Suppl):S79-S85.
46. Morrison J.J., et al. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. JAMA Surg 2013, 148(3):218-225.
47. Fries D., Innerhofer P., Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol 2009, 22(2):267-274.
48. Rourke C., et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012, 10(7):1342-1351.
49. Gollop N.D., et al. National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia. Transfus Med 2012, 22(5):350-355.
50. Tapia N.M., et al. TEG-guided resuscitation is superior to standardized MTP resuscitation in massively transfused penetrating trauma patients. J Trauma Acute Care Surg 2013, 74(2):378-385. discussion 385-6.
51. Rugeri L., et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007, 5(2):289-295.
52. Luddington R.J. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005, 27(2):81-90.
53. National Blood Authority Australia National Product Price List For 2012-13 http://www.blood.gov.au/what-blood-products-are-supplied-national-product-list.